VC  Samsara BioCapital

     Office Locations:

628 Middlefield Road
Palo Alto, CA 94301
Phone: 650-285-4270



  • Early



  • Life Sciences & Healthcare
  • Medical Device



    Samsara BioCapital was founded after years of the firm's partners working in the medical field and investment industry. Samsara's culture and philosophy are deeply rooted in a patient-first mentality. Samsara employs a long term, patient, company-build perspective with its portfolio, and collaborates with management to do what is best over the long run for the company, and for patients. Samsara provides capital through a company's full risk cycle and over many years, whether the company is private or public



      Fund Name



    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or Silicon Valley Database subscription.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Cory Freedland Partner
    Mike Dybbs Partner
    Srini Akkaraju Founder & Managing Partner


    Recent Funding Events (trailing 12 months):







      Delfi Diagnostics



      Series B


      Upstream Bio



      Series A


      Seismic Therapeutic



      Series A


      Dewpoint Therapeutics



      Series C


    Portfolio companies include:


    Recent News: